The Journal of Urology
Volume 177, Issue 6 , Page 2140, June 2007

Editorial Comment

Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(07)00717-3

doi:10.1016/j.juro.2007.01.269

Refers to article:

  • Low Dose Metronomic Oral Cyclophosphamide for Hormone Resistant Prostate Cancer: A Phase II Study

    R. Lord, S. Nair, A. Schache, J. Spicer, Navita Somaihah, V. Khoo, H. Pandha
    The Journal of Urology June 2007 (Vol. 177, Issue 6, Pages 2136-2140)

The Journal of Urology
Volume 177, Issue 6 , Page 2140, June 2007

Article Tools